Alfacell Corp (NASDAQOTH:ACEL.PK)

CAPS Rating: No stars

A biopharmaceutical company, primarily engaged in the discovery and development of a new therapeutic class of drugs for the treatment of cancer and other pathological conditions.

Recs

1
Player Avatar BigBioLover (< 20) Submitted: 4/20/2007 7:41:28 PM : Outperform Start Price: $2.78 ACEL.PK Score: -92.51

Greatest untold story in biotech. Will most likely be first RNAi product to market with many other applications to follow. Look towards anti-viral and cancer prophylactic.

Featured Broker Partners


Advertisement